|
1
|
Misra S, Chaturvedi A and Misra NC:
Gallbladder cancer. Curr Treat Options Gastroenterol. 9:95–106.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stinton LM and Shaffer EA: Epidemiology of
gallbladder disease: Cholelithiasis and cancer. Gut Liver.
6:172–187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eslick GD: Epidemiology of gallbladder
cancer. Gastroenterol Clin North Am. 39:307–330. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hundal R and Shaffer EA: Gallbladder
cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109.
2014.PubMed/NCBI
|
|
5
|
Misra S, Chaturvedi A, Misra NC and Sharma
ID: Carcinoma of the gallbladder. Lancet Oncol. 4:167–176. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levy AD, Murakata LA and Rohrmann CA Jr:
Gallbladder carcinoma: Radiologic-pathologic correlation.
Radiographics. 21:295–314. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sikora SS and Singh RK: Surgical
strategies in patients with gallbladder cancer: Nihilism to
optimism. J Surg Oncol. 93:670–681. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bonet Beltrán M, Allal AS, Gich I, Solé JM
and Carrió I: Is adjuvant radiotherapy needed after curative
resection of extrahepatic biliary tract cancers? A systematic
review with a meta-analysis of observational studies. Cancer Treat
Rev. 38:111–119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wistuba II, Sugio K, Hung J, Kishimoto Y,
Virmani AK, Roa I, Albores-Saavedra J and Gazdar AF:
Allele-specific mutations involved in the pathogenesis of endemic
gallbladder carcinoma in Chile. Cancer Res. 55:2511–2515.
1995.PubMed/NCBI
|
|
10
|
Landskron G, De la Fuente M, Thuwajit P,
Thuwajit C and Hermoso MA: Chronic inflammation and cytokines in
the tumor microenvironment. J Immunol Res. 2014:1491852014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh RK and Lokeshwar BL: The
IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling
to promote prostate cancer growth. Cancer Res. 71:3268–3277. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bai Z, Tai Y, Li W, Zhen C, Gu W, Jian Z,
Wang Q, Lin JE, Zhao Q, Gong W, et al: Gankyrin activates IL-8 to
promote hepatic metastasis of colorectal cancer. Cancer Res.
73:4548–4558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rashid A, Ueki T, Gao YT, Houlihan PS,
Wallace C, Wang BS, Shen MC, Deng J and Hsing AW: K-ras mutation,
p53 overexpression, and microsatellite instability in biliary tract
cancers: A population-based study in China. Clin Cancer Res.
8:3156–3163. 2002.PubMed/NCBI
|
|
14
|
Wang H, Ding W, Yang D, Gu T, Yang S and
Bai Z: Different concentrations of 17β-estradiol modulates
apoptosis induced by interleukin-1β in rat annulus fibrosus cells.
Mol Med Rep. 10:2745–2751. 2014.PubMed/NCBI
|
|
15
|
Suzuki H and Ikeda K: Mode of action of
long-term low-dose macrolide therapy for chronic sinusitis in the
light of neutrophil recruitment. Curr Drug Targets Inflamm Allergy.
1:117–126. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang HY, Wang F, Chen HM and Yan XJ:
κ-carrageenan induces the disruption of intestinal epithelial
Caco-2 monolayers by promoting the interaction between intestinal
epithelial cells and immune cells. Mol Med Rep. 8:1635–1642.
2013.PubMed/NCBI
|
|
17
|
Giovanni Germano, Paola Allavena and
Mantovani A: Cytokines as a key component of cancer-related
inflammation. Cytokine. 43:374–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Herman AP, Krawczyńska A, Bochenek J,
Dobek E, Herman A and Tomaszewska-Zaremba D: LPS-induced
inflammation potentiates the IL-1β-mediated reduction of LH
secretion from the anterior pituitary explants. Clin Dev Immunol.
2013:9269372013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Voronov E, Carmi Y and Apte RN: Role of
IL-1-mediated inflammation in tumor angiogenesis. Adv Exp Med Biol.
601:265–270. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lewis AM, Varghese S, Xu H and Alexander
HR: Interleukin-1 and cancer progression: The emerging role of
interleukin-1 receptor antagonist as a novel therapeutic agent in
cancer treatment. J Transl Med. 4:482006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tu S, Bhagat G, Cui G, Takaishi S,
Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl
O, Fox JG and Wang TC: Overexpression of interleukin-1beta induces
gastric inflammation and cancer and mobilizes myeloid-derived
suppressor cells in mice. Cancer Cell. 14:408–419. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miki C, Konishi N, Ojima E, Hatada T,
Inoue Y and Kusunoki M: C-reactive protein as a prognostic variable
that reflects uncontrolled up-regulation of the IL-1-IL-6 network
system in colorectal carcinoma. Dig Dis Sci. 49:970–976. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Krelin Y, Voronov E, Dotan S, Elkabets M,
Reich E, Fogel M, Huszar M, Iwakura Y, Segal S, Dinarello CA and
Apte RN: Interleukin-1beta-driven inflammation promotes the
development and invasiveness of chemical carcinogen-induced tumors.
Cancer Res. 67:1062–1071. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Voronov E, Shouval DS, Krelin Y, Cagnano
E, Benharroch D, Iwakura Y, Dinarello CA and Apte RN: IL-1 is
required for tumor invasiveness and angiogenesis. Proc Natl Acad
Sci USA. 100:2645–2650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Soria G, Ofri-Shahak M, Haas I,
Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, Weitzenfeld P,
Meshel T, Shabtai E, Gutman M and Ben-Baruch A: Inflammatory
mediators in breast cancer: Coordinated expression of TNFα &
IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal
transition. BMC Cancer. 11:1302011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Colasante A, Mascetra N, Brunetti M,
Lattanzio G, Diodoro M, Caltagirone S, Musiani P and Aiello FB:
Transforming growth factor beta 1, interleukin-8 and interleukin-1,
in non-small-cell lung tumors. Am J Respir Crit Care Med.
156:968–973. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Apte RN and Voronov E: Interleukin-1 - a
major pleiotropic cytokine in tumor-host interactions. Semin Cancer
Biol. 12:277–290. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang Q, Lan F, Wang X, Yu Y, Ouyang X,
Zheng F, Han J, Lin Y, Xie Y, Xie F, et al: IL-1β-induced
activation of p38 promotes metastasis in gastric adenocarcinoma via
upregulation of AP-1/c-fos, MMP2 and MMP9. Mol Cancer. 13:182014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Petrella BL and Vincenti MP:
Interleukin-1β mediates metalloproteinase-dependent renal cell
carcinoma tumor cell invasion through the activation of CCAAT
enhancer binding protein β. Cancer Med. 1:17–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stetler-Stevenson WG and Yu AE: Proteases
in invasion: Matrix metalloproteinases. Semin Cancer Biol.
11:143–152. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mantovani A and Dejana E: Cytokines as
communication signals between leukocytes and endothelial cells.
Immunol Today. 10:370–375. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Strieter RM, Polverini PJ, Arenberg DA and
Kunkel SL: The role of CXC chemokines as regulators of
angiogenesis. Shock. 4:155–160. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Folkman J and D'Amore PA: Blood vessel
formation: What is its molecular basis? Cell. 87:1153–1155. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dinarello CA: Biologic basis for
interleukin-1 in disease. Blood. 87:2095–2147. 1996.PubMed/NCBI
|
|
35
|
Li Y, Wang L, Pappan L, Galliher-Beckley A
and Shi J: IL-1β promotes stemness and invasiveness of colon cancer
cells through Zeb1 activation. Mol Cancer. 11:872012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kaler P, Galea V, Augenlicht L and
Klampfer L: Tumor associated macrophages protect colon cancer cells
from TRAIL-induced apoptosis through IL-1beta-dependent
stabilization of Snail in tumor cells. PLoS One. 5:e117002010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Martin A and Cano A: Tumorigenesis: Twist1
links EMT to self-renewal. Nat Cell Biol. 12:924–925. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou
X, Zhang ZJ, Peng YH, Yang YZ and Yun JP: miR-720 inhibits tumor
invasion and migration in breast cancer by targeting TWIST1.
Carcinogenesis. 35:469–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qian J, Luo Y, Gu X, Zhan W and Wang X:
Twist1 promotes gastric cancer cell proliferation through
up-regulation of FoxM1. PLoS One. 8:e776252013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chang TM and Hung WC: Transcriptional
repression of TWIST1 gene by Prospero-related homeobox 1 inhibits
invasiveness of hepatocellular carcinoma cells. FEBS Lett.
586:3746–3752. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chang LH, Chen CH, Huang DY, Pai HC, Pan
SL and Teng CM: Thrombin induces expression of twist and cell
motility via the hypoxia-inducible factor-1α translational pathway
in colorectal cancer cells. J Cell Physiol. 226:1060–1068. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
van Nes JG, de Kruijf EM, Putter H,
Faratian D, Munro A, Campbell F, Smit VT, Liefers GJ, Kuppen PJ,
van de Velde CJ and Bartlett JM: Co-expression of SNAIL and TWIST
determines prognosis in estrogen receptor-positive early breast
cancer patients. Breast Cancer Res Treat. 133:49–59. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gajula RP, Chettiar ST, Williams RD,
Thiyagarajan S, Kato Y, Aziz K, Wang R, Gandhi N, Wild AT, Vesuna
F, et al: The twist box domain is required for Twist1-induced
prostate cancer metastasis. Mol Cancer Res. 11:1387–1400. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Feng MY, Wang K, Song HT, Yu HW, Qin Y,
Shi QT and Geng JS: Metastasis-induction and apoptosis-protection
by TWIST in gastric cancer cells. Clin Exp Metastasis.
26:1013–1023. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Espinoza JA, Bizama C, García P, Ferreccio
C, Javle M, Miquel JF, Koshiol J and Roa JC: The inflammatory
inception of gallbladder cancer. Biochim Biophys Acta. 1865:245–54.
2016.PubMed/NCBI
|
|
46
|
Kumar S and Kumar S and Kumar S: Infection
as a risk factor for gallbladder cancer. J Surg Oncol. 93:633–639.
2006. View Article : Google Scholar : PubMed/NCBI
|
